Skip to main content
. 2017 Dec 5;8(67):111902–111911. doi: 10.18632/oncotarget.22950

Table 2. The comparison of the four-plasma miRNA signature and the panel of three miRNAs in a development cohort and a validation cohort.

A development cohort A validation cohort
Sensitivity (95% CI)* Specificity (95% CI)* Sensitivity (95% CI)* Specificity (95% CI)*
The four-plasma miRNA signature 91.56 (83.58 to 96.17) 96.23 (90.36% to 99.29%) 91.18 (76.32 to 98.14) 96.67 (82.78 to 99.92)
The panel of three miRNAs 75.46 (64.89 to 83.45) 85.26 (76.06% to 91.89%) 76.47 (58.83 to 89.25) 83.33 (65.28 to 94.36)

Abbreviations: CI, confidence interval.

* P<0.05.